(trying to be Nigel)......
Tuesday March 7, 5:50 pm Eastern Time
Company Press Release
SOURCE: Corixa Corporation
Corixa Files Registration Statement for Follow-On
Public Offering Of 2,250,000 Shares of Common Stock
SEATTLE, March 7 /PRNewswire/ -- Corixa Corporation (Nasdaq: CRXA - news) today announced it has filed a
registration statement with the Securities and Exchange Commission (SEC) for a proposed follow-on public offering of
2,250,000 shares of Common Stock. Corixa is a biotechnology company focused on understanding and directing the immune
system to treat and prevent autoimmune diseases, cancer and infectious diseases.
Of the 2,250,000 shares of Common Stock proposed to be offered, 2,000,000 are being offered by the Company and
250,000 are being offered by a selling stockholder of the Company. The shares will be offered by an underwriting group led by
Warburg Dillon Read LLC, Lehman Brothers Inc., Prudential Vector Healthcare, a unit of Prudential Securities, and Pacific
Growth Equities, Inc. (snip) |
